The International Diabetes Federation (IDF) is finalizing updated global guidelines for Type 2 diabetes management, set to be launched during the World Congress in Bangkok, April 2025. These guidelines were developed with a flexible approach to assist countries in providing patient-centred diabetes care that adapts to their specific settings and capabilities.
“These guidelines are grounded in science but flexible enough to be applied in diverse healthcare settings,” said IDF president Peter Schwarz, who recently visited Chennai with the guidelines committee chairperson, Professor Antonio Ceriello. Together, they provided Indian diabetologists with an overview of the guidelines, which prioritize insulin as the foundational therapy over newer, more costly drugs like GLP-1 receptor agonists. “We aim to empower local healthcare providers with effective options that respect both patient rights and treatment affordability,” noted Professor Ceriello.
The IDF guidelines prioritize patient-centered care, focusing on basic diabetes management that adapts to each country’s economic environment. Digital tools like CGM and AI-driven interventions provide new opportunities for early diagnosis and lifestyle support in diabetes care globally - Peter Schwarz, IDF President
While other organizations such as the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have developed treatment algorithms in accordance with best practices, the IDF’s framework considers accessibility and affordability challenges worldwide. With more than 240 member associations globally, the IDF seeks to create a universal standard that resonates across varied healthcare infrastructures.
The IDF guidelines set a fundamental standard for diabetes care, ensuring access to necessary treatments regardless of a patient’s location - Antonio Ceriello, Guidelines committee chairperson
The IDF is also developing a Global Diabetes Index, a groundbreaking project that will annually measure diabetes care quality worldwide based on feedback from 100,000 physicians and 100,000 patients. This index will enable cross-country comparisons, fostering a learning exchange of best practices across regions.
In India, effective diabetes management must consider affordability and accessibility due to the high out-of-pocket healthcare spending. With CGM, insulin pumps, and emerging potential cures, we have promising paths to better control and quality of life for diabetes patients - V. Mohan, Chairman, Dr. Mohan’s Diabetes Specialities Centre
